Sponsor or institution
Clinical trials and research at Fibronox, L.l.c.
As of November 12, 2026, Find a Trial lists 2 NIH-funded research projects at this institution, with $1.4 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2NIH research projects
NIH-funded research (2)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
New medicines to block Nox4 and reduce lung scarring in pulmonary fibrosis
Developing drugs that block an enzyme called Nox4 to try to slow or stop scarring in the lungs of people with pulmonary fibrosis.
-
Using existing drugs to create a new inhaled treatment for lung scarring
This study is exploring a new inhaled treatment using existing medications to help improve lung function in people with idiopathic pulmonary fibrosis (IPF) by boosting the body's natural defenses against damage, especially as we age.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.